SHAIK, MOHAMMED MONSOOR
 Distribuzione geografica
Continente #
EU - Europa 3.172
NA - Nord America 1.775
AS - Asia 1.425
SA - Sud America 207
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 41
OC - Oceania 3
Totale 6.718
Nazione #
SE - Svezia 1.869
US - Stati Uniti d'America 1.705
IT - Italia 785
SG - Singapore 425
CN - Cina 281
VN - Vietnam 198
HK - Hong Kong 175
BR - Brasile 149
RU - Federazione Russa 131
IN - India 69
GB - Regno Unito 67
BD - Bangladesh 64
FR - Francia 56
DE - Germania 44
NL - Olanda 44
KR - Corea 41
CA - Canada 36
JP - Giappone 29
ES - Italia 28
PL - Polonia 27
FI - Finlandia 26
IE - Irlanda 26
ID - Indonesia 23
TR - Turchia 21
AR - Argentina 20
PK - Pakistan 16
DK - Danimarca 15
ZA - Sudafrica 15
IQ - Iraq 14
MX - Messico 13
CL - Cile 10
CO - Colombia 10
BE - Belgio 9
MY - Malesia 9
SA - Arabia Saudita 9
AT - Austria 8
MA - Marocco 8
PH - Filippine 8
UA - Ucraina 8
EC - Ecuador 7
UZ - Uzbekistan 7
CR - Costa Rica 6
IL - Israele 6
VE - Venezuela 6
LB - Libano 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
NP - Nepal 4
PT - Portogallo 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
EE - Estonia 3
ET - Etiopia 3
JM - Giamaica 3
JO - Giordania 3
LT - Lituania 3
NI - Nicaragua 3
PY - Paraguay 3
AL - Albania 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
KG - Kirghizistan 2
MK - Macedonia 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
VC - Saint Vincent e Grenadine 1
Totale 6.623
Città #
Stockholm 1.866
Milan 291
Singapore 273
Ashburn 238
San Jose 183
Hong Kong 164
Council Bluffs 79
Los Angeles 72
Ho Chi Minh City 68
Santa Clara 66
Hefei 64
Washington 58
Hanoi 56
Rome 49
New York 46
Seoul 38
Chicago 37
Beijing 35
Dallas 35
Buffalo 30
Tokyo 28
Dublin 27
Phoenix 27
Columbus 26
São Paulo 25
Florence 20
Helsinki 20
Boardman 19
Bologna 19
Warsaw 19
Frankfurt am Main 18
Jakarta 18
Shanghai 18
Amsterdam 16
Naples 16
Paris 15
Hyderabad 14
Maastricht 14
The Dalles 14
Turin 14
Chennai 13
Figino 13
Houston 13
Orem 13
London 12
Philadelphia 12
Sassuolo 12
Atlanta 11
Copenhagen 11
Denver 11
Johannesburg 11
Lauterbourg 11
Brescia 10
Brooklyn 10
Boston 9
Novate Milanese 9
Biloxi 8
Desio 8
Montreal 8
Nuremberg 8
Toronto 8
Barnet 7
Haiphong 7
Hangzhou 7
Kuala Lumpur 7
Poplar 7
Rometta 7
Sorbolo 7
Tashkent 7
Baghdad 6
Dhaka 6
Istanbul 6
Moscow 6
Parma 6
Queens 6
Santiago 6
Seattle 6
Brasília 5
Charlotte 5
Da Nang 5
Guangzhou 5
Kent 5
Krakow 5
Lappeenranta 5
Leiden 5
Mumbai 5
New Delhi 5
Palermo 5
Pisogne 5
Reading 5
Salt Lake City 5
San Francisco 5
San Giuliano Terme 5
San José 5
Verona 5
Vienna 5
Belém 4
Berlin 4
Bexley 4
Bogotá 4
Totale 4.571
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 2.043
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 429
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 330
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 319
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 312
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 308
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 300
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 270
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 257
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 254
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection 233
Self-Activated Fluorescent Hydroxyapatite Nanoparticles: A Promising Agent for Bioimaging and Biolabeling 194
Ellagic acid containing collagen-chitosan scaffolds as potential antioxidative bio-materials for tissue engineering applications 181
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 179
Antioxidant-antibacterial containing bi-layer scaffolds as potential candidates for management of oxidative stress and infections in wound healing 176
Novel melt-down neutralization method for synthesis of chitosan-silver scaffolds for tissue engineering applications 164
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants 118
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators 90
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants 88
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS 82
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 73
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 65
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 65
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 64
Harnessing Immunity: Synthesis of New Modulators of Toll-like Receptor 4 (TLR4) 50
HARNESSING IMMUNITY: SYNTHESIS OF NEW MODULATORS OF TOLL-LIKE RECEPTOR 4 (TLR4) 46
Design and synthesis of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy 28
Totale 6.718
Categoria #
all - tutte 16.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202330 0 0 0 0 0 0 0 0 0 18 7 5
2023/2024226 1 7 48 18 12 23 27 2 22 18 17 31
2024/2025989 29 66 95 62 68 52 60 33 77 149 85 213
2025/20264.474 229 141 153 285 234 110 332 129 273 2.200 120 268
2026/2027999 156 156 356 331 0 0 0 0 0 0 0 0
Totale 6.718